Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bartkova, 1996, The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis, Cancer Res, 56, 5475
Halaban, 1998, Melanomas, from the cell cycle point of view (Review), Int J Mol Med, 1, 419
Roesch A, Becker B, Meyer S, et al. Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanoma. Mod Pathol 2004, Epub ahead of print.
Defeo-Jones, 1991, Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product, Nature, 352, 251, 10.1038/352251a0
Vogt, 1999, Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of sporadic human melanoma skin cancer, Lab Invest, 79, 1615
Kashuba, 2000, Isolation and chromosomal localization of a new human retinoblastoma binding protein 2 homologue 1a (RBBP2H1A), Eur J Hum Genet, 8, 407, 10.1038/sj.ejhg.5200474
Barrett, 2002, PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer/testis antigen?, Int J Cancer, 101, 581, 10.1002/ijc.10644
Lu, 1999, A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer, J Biol Chem, 274, 15633, 10.1074/jbc.274.22.15633
Tan, 2003, Human PLU-1 Has transcriptional repression properties and interacts with the developmental transcription factors BF-1 and PAX9, J Biol Chem, 278, 20507, 10.1074/jbc.M301994200
Meehan, 2004, Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription, J Biol Chem, 279, 1562, 10.1074/jbc.M307969200
Fattaey, 1993, Characterization of the retinoblastoma binding proteins RBP1 and RBP2, Oncogene, 8, 3149
Kim, 1994, Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein, Mol Cell Biol, 14, 7256
Hafner, 2003, Loss of EphB6 expression in metastatic melanoma, Int J Oncol, 23, 1553
Gehlsen, 1992, Integrin expression in human melanoma cells with differing invasive and metastatic properties, Clin Exp Metastasis, 10, 111, 10.1007/BF00114587
Hafner, 2004, Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers, Clin Chem, 50, 490, 10.1373/clinchem.2003.026849
Rumpler, 2003, Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes, Exp Dermatol, 12, 761, 10.1111/j.0906-6705.2003.00082.x
Tang, 2000, Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastoma, Med Pediatr Oncol, 35, 656, 10.1002/1096-911X(20001201)35:6<656::AID-MPO37>3.0.CO;2-A
Tang, 2001, Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas, Med Pediatr Oncol, 36, 80, 10.1002/1096-911X(20010101)36:1<80::AID-MPO1019>3.0.CO;2-N
Kononen, 1998, Tissue microarrays for high-throughput molecular profiling of tumor specimens, Nat Med, 4, 844, 10.1038/nm0798-844
Kaelin, 1997, Recent insights into the functions of the retinoblastoma susceptibility gene product, Cancer Invest, 15, 243, 10.3109/07357909709039722
Taya, 1997, RB kinases and RB-binding proteins: new points of view, Trends Biochem Sci, 22, 14, 10.1016/S0968-0004(96)10070-0